Target intelligence / Profile preview

Ribosomal protein SA pseudogene 68 (RPSAP68)

Target
RPSAP68
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein SA pseudogene 68 (RPSAP68) is a pseudogene in the human genome. It shares sequence similarity with the functional ribosomal protein SA (RPSA) gene, which encodes a structural component of the ribosome and also functions as a cell surface receptor (notably for laminin)[1][3]. RPSAP68 itself does not encode a functional protein and is not classified as a receptor, enzyme, transporter, or other drug target. Like most processed pseudogenes, it likely arises from retrotransposition and accumulates mutations that prevent it from generating a functional product[4][7]. There is no evidence for its involvement in normal biology, disease processes, or as a therapeutic target. Important note: The entry “Ribosomal protein SA pseudogene 68 (RPSAP68)” appears to refer to a non-coding, non-functional pseudogene rather than a canonical target or biologically significant entity. Therefore, RPSAP68 is not a therapeutic target, does not have known biological or disease roles, and does not have associated biomarkers, drugs, or safety concerns. If the intended target was the functional ribosomal protein SA (RPSA; also called 37/67 kDa Laminin Receptor), refer instead to “Ribosomal protein SA (RPSA)” for relevant structured information[1][3][7].

02

Biological functions

None known; pseudogenes are generally considered non-functional, although some may exert regulatory functions as non-coding RNA in rare cases
03

Disease associations

None known; RPSAP68 does not have described roles in disease or as a biomarker.

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 68 (RPSAP68).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 68 (RPSAP68).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call